{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:46:59Z","timestamp":1772120819534,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA-021319"],"award-info":[{"award-number":["DA-021319"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["KO5 DA 031749"],"award-info":[{"award-number":["KO5 DA 031749"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.drugalcdep.2018.04.018","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T14:01:08Z","timestamp":1527256868000},"page":"318-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Hypocretin\/orexin antagonists decrease cocaine self-administration by female rhesus monkeys"],"prefix":"10.1016","volume":"188","author":[{"given":"Richard W.","family":"Foltin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzette M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbr.2014.06.049","article-title":"Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL\/6J mice: pharmacological and molecular evidence of orexin involvement","volume":"272","author":"Alcaraz-Iborra","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bph.12639","article-title":"Orexin\/hypcretin role in reward: implications for opioid and other addictions","volume":"172","author":"Baimel","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ejn.12866","article-title":"Orexin-1 receptor signaling increases motivation for cocaine-associated cues","volume":"41","author":"Bentzley","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0020","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/npp.2011.310","article-title":"Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia","volume":"37","author":"Bettica","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ncomms2461","article-title":"Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction","volume":"4","author":"Blouin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0035","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","article-title":"Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers","volume":"29","author":"Borgland","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnbeh.2013.00059","article-title":"Hypocretins and the reward function: what have we learned so far?","volume":"7","author":"Boutrel","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0045","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0507480102","article-title":"Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior","volume":"102","author":"Boutrel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbr.2015.05.051","article-title":"Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep","volume":"291","author":"Brodnik","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0055","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.1205-09.2009","article-title":"Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions","volume":"29","author":"Carter","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00213-013-3051-7","article-title":"Attenuation of saccharin-seeking in rats by orexin\/hypocretin receptor 1 antagonist","volume":"228","author":"Cason","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2014.07.007","article-title":"Role of orexin\/hypocretin in conditioned sucrose-seeking in female rats","volume":"86","author":"Cason","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yhbeh.2012.10.008","article-title":"Effects of menstrual cycle phases on cocaine self-administration in rhesus macaques","volume":"63","author":"Cooper","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-009-1588-2","article-title":"Hypocretin mechanisms in nicotine addiction: evidence and speculation","volume":"206","author":"Corrigall","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0080","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.euroneuro.2014.05.002","article-title":"Pharmacokinetic and pharmacodynamics interactions between almorexant, a dual orexin receptor antagonist, and desipramine","volume":"24","author":"Cruz","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0085","doi-asserted-by":"crossref","first-page":"14239","DOI":"10.1523\/JNEUROSCI.3878-07.2007","article-title":"Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates","volume":"27","author":"Deadwyler","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0090","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"de Lecea","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin\u2013orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-010-2048-8","article-title":"Hypocretin 1\/Orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration","volume":"214","author":"Espa\u00f1a","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/adb.12507","article-title":"Suvorexant, an orexin\/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine","volume":"23","author":"Gentile","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2014.07.006","article-title":"Hypocretin (orexin) neuromodulation of stress and reward pathways","volume":"29","author":"Giardino","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.biopsych.2016.10.013","article-title":"Orexins mediate sex differences in the stress response and in cognitive flexibility","volume":"81","author":"Grafe","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0125","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/npp.2013.62","article-title":"An orexin hotspot in ventral pallidum amplifies hedonic \u2018liking\u2019 for sweetness","volume":"38","author":"Ho","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/clpt.2011.370","article-title":"Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial","volume":"91","author":"Hoever","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnbeh.2012.00047","article-title":"Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence","volume":"6","author":"Hollander","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/FBP.0b013e328343d761","article-title":"Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward","volume":"22","author":"Hutcheson","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuropharm.2014.06.015","article-title":"Concurrent and robust regulation of feeding behaviors and metabolism by orexin neurons","volume":"85","author":"Inutsuka","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-013-3248-9","article-title":"Hindbrain orexin 1 receptors influence palatable food intake, operant responding for food, and food-conditioned place preference in rats","volume":"231","author":"Kay","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1901\/jeab.1966.9-475","article-title":"Conditioned reinforcement in second-order schedules","volume":"9","author":"Kelleher","year":"1966","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0165","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00213-017-4673-y","article-title":"Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling","volume":"234","author":"Levy","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-012-2681-5","article-title":"Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats","volume":"226","author":"Mahler","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.107.125732","article-title":"Quantification of phosphorylated camp-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin a-containing neurons","volume":"323","author":"McPherson","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-008-1136-5","article-title":"Inhibition of orexin-1\/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long\u2013Evans rats","volume":"199","author":"Richards","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2014.09.002","article-title":"Orexin-1 receptor antagonist in central nucleus of the amygdala attenuates the acquisition of flavor-taste preference in rats","volume":"126","author":"Risco","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0143-4179(02)00085-9","article-title":"Orexins and appetite regulation","volume":"36","author":"Rodgers","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and g protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biopsych.2016.06.010","article-title":"Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats","volume":"81","author":"Schmeichel","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjp.0703953","article-title":"SB-334867-A: the first selective orexin-1 receptor antagonist","volume":"132","author":"Smart","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0210","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1460-9568.2012.08013.x","article-title":"Orexin\u200a\/\u200ahypocretin-1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking","volume":"35","author":"Smith","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1460-9568.2009.06844.x","article-title":"Orexin\/hypocretin signaling at the orexin-1 receptor regulates cue-elicited cocaine-seeking","volume":"30","author":"Smith","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2009.06.042","article-title":"Orexin\/hypocretin is necessary for context-driven cocaine-seeking","volume":"58","author":"Smith","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrn808","article-title":"The hypocretins: setting the arousal threshold","volume":"3","author":"Sutcliffe","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopsych.2009.01.018","article-title":"Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network","volume":"65","author":"Wang","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuropharm.2009.07.008","article-title":"Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure","volume":"58","author":"Winrow","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0240","first-page":"491","article-title":"Use of subcutaneous vascular access ports in rhesus monkeys","volume":"44","author":"Wojnicki","year":"1994","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0245","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","article-title":"Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness","volume":"23","author":"Zeitzer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.04.018_bib0250","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.111.187567","article-title":"Orexin-1 receptor mediation of cocaine seeking in male and female rats","volume":"340","author":"Zhou","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T09:02:22Z","timestamp":1534842142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618302801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"alternative-id":["S0376871618302801"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733330341.793546697","asserted-by":"object"}]},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypocretin\/orexin antagonists decrease cocaine self-administration by female rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}